|
1
|
ritonavir
|
United States
|
Ritonavir is frequently used as a protease inhibitor for HIV/AIDS treatment in the United States.
|
5
|
|
2
|
ritonavir
|
Europe
|
Ritonavir is commonly used in Europe as an antiretroviral medication for HIV/AIDS.
|
4
|
|
3
|
ritonavir
|
India
|
Ritonavir is a standard part of HIV/AIDS therapy in India, but limited accessibility due to costs and resources in some regions.
|
3
|
|
4
|
ritonavir
|
South Africa
|
Ritonavir is used in HIV/AIDS treatment in South Africa, but its availability is limited by economic factors in some areas.
|
2
|
|
5
|
ritonavir
|
Western countries
|
Ritonavir is a commonly used protease inhibitor in Western countries for the treatment of HIV/AIDS.
|
2
|
|
6
|
ritonavir
|
Africa
|
Ritonavir is less accessible in Africa due to high cost and limited healthcare resources.
|
1
|
|
7
|
ritonavir
|
Developing countries
|
Access to antiretroviral medication like ritonavir may be limited in developing countries due to resource constraints and healthcare infrastructure challenges.
|
1
|
|
8
|
ritonavir
|
North Africa
|
Ritonavir is not commonly used in traditional medicine in North Africa.
|
1
|
|
9
|
ritonavir
|
Sub-Saharan Africa
|
Limited access to ritonavir and other antiretroviral medications in Sub-Saharan Africa may be due to resource constraints and healthcare infrastructure challenges.
|
1
|